The effect of tibolone on cardiac flow in postmenopausal women with non-insulin dependent diabetes mellitus

Maturitas

Volumn 27, Issue 1, 1997, Pages 85-90

  Prelevic, Gordana M ^a,c   Beljic, Teodora ^b   Ginsburg, Jean ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ZVEZDARA UNIVERSITY MEDICAL CENTER   (Serbia)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

cardiac flow; menopause; non insulin dependent diabetes; tibolone

Indexed keywords

TIBOLONE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART DISEASE; HEART FUNCTION; HEART OUTPUT; HEART VOLUME; HUMAN; MEASUREMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; ULTRASOUND;

ANABOLIC AGENTS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CORONARY CIRCULATION; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MIDDLE AGED; NORPREGNENES; POSTMENOPAUSE; PROSPECTIVE STUDIES;

EID: 0031006157     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(97)01114-6     Document Type: Article

References (21)

1. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham study. Am Heart J 1987; 114: 413-419.
2. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner B, Arky RA, Speizer FE, Hennekens CH. A prospective study of maturity onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141-1147.
3. Barrett-Connor E, Bush TL, Estrogen and coronary heart disease in women. J Am Med Assoc 1991; 265: 1861-1867.
4. Bush TL, Barrett-Connor E, Cowan DK, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987; 75: 1102.
5. PEPI trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. J Am Med Assoc 1995; 273: 199-208.
6. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990; 81: 1680-1687.
7. Jiang CW, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17-beta oestradiol in vitro. Br J Pharmacol 1991; 104: 1033-1037.
8. Collins P, Rosano GMC, Carrel PM et al. 17β -oestradiol attenuates acetylcholine-induced coronary arteria; constriction in women but not men with coronary heart disease. Circulation 1995; 92: 24-30.
9. Ginsburg J, Hardiman P. Cardiovascular effects of transdermal oestradiol in postmenopausal women. Ann NY Acad Sci 1990; 592: 424-425.
10. Hardiman P, Nihoyannopoulos P, Kicovic P, Ginsburg G. Cardiovascular effects of Org OD 14 - a new steroid therapy for climacteric symptoms. Maturitas 1991; 13: 235-242.
11. Prelevic GM, Beljic T. The effect of oestrogen and progestrogen replacement therapy on systolic flow velocity in healthy postmenopausal women. Maturitas 1994; 20: 37-44.
12. Bourne T, Hillard TC, Whitehead MI, Crook D, Campbell S. Oestrogens, arterial status and postmenopausal women. Lancet 1990; 335: 1470-1471.
13. Gangar FK, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991; 338: 839-842.
14. Pines A, Fisman EZ, Levo Y, Averbuch M, Lidor A, Drory Y, Finkelstein A, Hetman-Peri M, Moshkowitz M, Ben-Ari E, Ayalon D. The effect of hormone replacement therapy in normal postmenopausal women: measurements of Doppler-derived parameters of aortic flow. Am J Obstet Gynecol 1991; 164: 806-812.
15. Punnonen R, Liukko P, Cortes-Prieto J, Eydam F, Milojevic S, Trevoux R, Chryssikoloulos E, Franchi F, Luisi M, Kicovic PM. Multicentre study of effects of Org OD 14 on endometrium, vaginal cytology and cervical mucus in post-menopausal and oophorectomized women. Maturitas 1984; 5: 281-286.
16. Genazzani AR, Benedek-Jaszmann LJ, Hart DM, Andolsek L, Kicovic PM, Tax L. Org OD 14 and the endometrium. Maturitas 1991; 13: 243-251.
17. Jewitt D, Gobe I, Millis C, Maurer B, Thomas M, Shillinford J. Aortic velocity and acceleration measurements in the assessment of coronary heart disease. Eur J Cardiol 1974; 1: 249-305.
18. Benjamin EJ, Levy D, Anderson KM, Wolf PS, Plehn SF, Evans JC, Comai K, Fuller DL, St. John Sutton M. Determinants of Doppler indexes of left ventricular diastolic function in normal subjects (The Framingham Heart Study). Am J Cardiol 1992; 70: 508-515.
19. Zarich SW, Nesto RW. Diabetic cardiomyopathy. Am Heart J 1989; 118: 1000-1012.
20. Riggs TW, Transue D. Doppler echocardiographic evaluation of left ventricular diastolic function in adolescents with diabetes mellitus. Am J Cardiol 1990; 65: 899-902.
21. Beljic T, Miric M. Improved metabolic control does not reverse left ventricular filling abnormalities in newly diagnosed non-insulin-dependent diabetes patients. Acta Diabetol 1994; 31: 147-150.